1.
Clinical observation on rituximab combined with chemotherapy in the treatment of diffused large B cell lymphoma
利妥昔单抗联合化疗治疗弥漫型大B细胞淋巴瘤的临床观察
2.
Prognostic Evalution of Immunohistochemical Profiles in Diffuse Large B-cell Lymphoma
弥漫大B细胞淋巴瘤的免疫表型与预后的关系
3.
Differences of the nuclear morphological parameters in molecular subtypes of diffuse large B-cell lymphoma(DLBCL)
弥漫大B细胞淋巴瘤分子亚型的细胞核形态参数的差异
4.
State of Chromosome 3q27 and Different Subtypes of Diffuse Large B-cell Lymphoma and Their Prognostic Relation
弥漫性大B细胞淋巴瘤3q27染色体状态和不同亚型与预后的关系
5.
A Clinical Observation of the Therapeutic Effects with R-CHOP Regimen on the Initially Diagnosed Diffuse Large B-Cell Lymphoma
R-CHOP方案治疗25例初治弥漫大B细胞型淋巴瘤的临床观察
6.
Immunohistochemical profiles and their prognostic role in diffuse large B-cell lymphoma
弥漫大B细胞淋巴瘤的免疫学亚型与预后的关系
7.
Short-term efficacy of rituximab-CHOP and CHOP regimens on two subtypes of diffuse large B-cell lymphoma
R-CHOP和CHOP方案治疗两种亚型弥漫大B细胞淋巴瘤患者的近期疗效
8.
An Observation of the Therapeutic Effects with R-CHOP Regimen in Diffuse Large B-cell Lymphoma;
R-CHOP方案治疗弥漫大B细胞淋巴瘤的疗效观察
9.
The Analysis of Prognostic Factors in 70 Cases of Diffuse Large B-cell Lymphoma
70例弥漫大B细胞淋巴瘤相关预后因素的分析
10.
The significance of SELDI-TOF-MS technique applied in diffuse large B-cell lymphoma
SELDI-TOF-MS在弥漫性大B细胞淋巴瘤中的意义
11.
A study of the expression of Bcl-2 and Bcl-6 in diffuse large B-cell lymphoma.
Bcl-2、Bcl-6在弥漫大B细胞淋巴瘤中表达的研究
12.
Expressions of bcl-6,lpp and miR-28 Genes in Diffuse Large B Cell Lymphoma Cell Lines
弥漫大B细胞淋巴瘤细胞系中bcl-6、lpp和miR-28基因表达的研究
13.
A Clinicopathologic Study of Diffuse Large B-cell Lymphoma with Emphysis on Immunophenotypic Subtypes and Genetic Abnormalities;
弥漫性大B细胞淋巴瘤临床病理特征、免疫学亚型和遗传学异常研究
14.
Distinct Distributions of Immunohistochemical Subgroups, Cytogenetic Profiles and BCL2 Expression Mechanism of Diffuse Large B-cell Lymphoma in Chinese Patients
中国人弥漫性大B细胞淋巴瘤免疫学亚型、遗传学异常和BCL2蛋白表达机制的研究
15.
Feature of distribution and clonal expansion of TCR Vβ subfamily in T cells from peripheral blood in patients with DLBL
弥漫大B型非霍奇金淋巴瘤患者外周血TCR Vβ亚家族T细胞分布和克隆性增生特点
16.
Clinical Significance of the Expression of Skp2, P27 and Ki67 in Diffuse Large B-Cell Lymphoma;
SKP2、P27及Ki67在弥漫性大B细胞淋巴瘤中表达的临床意义
17.
Study on the Interrelationship of LGT and the Prognosis of Patients with Diffused Large B Cell Lymphoma;
LGT蛋白组与弥漫大B细胞淋巴瘤患者预后相关性的研究
18.
Clinical Investigation of Rituximab in Combination with CHOP Chemotherapy for Diffuse Large B Cell Lymphoma;
美罗华联合化疗治疗弥漫性大B细胞淋巴瘤的临床研究